These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2372762)

  • 1. Long-term cardiac sequelae after treatment of malignant tumors with radiotherapy or cytostatics in childhood.
    Mäkinen L; Mäkipernaa A; Rautonen J; Heino M; Pyrhönen S; Laitinen LA; Siimes MA
    Cancer; 1990 May; 65(9):1913-7. PubMed ID: 2372762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late cardiotoxicity after treatment for a malignant bone tumor.
    Postma A; Bink-Boelkens MT; Beaufort-Krol GC; Kengen RA; Elzenga NJ; Schasfoort-van Leeuwen MJ; Schraffordt koops H; Kamps WA
    Med Pediatr Oncol; 1996 Apr; 26(4):230-7. PubMed ID: 8600333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Special focus on cardiac toxicity of different sequences of adjuvant doxorubicin/docetaxel/CMF regimens combined with radiotherapy in breast cancer patients.
    Magné N; Castadot P; Chargari C; Di Leo A; Philippson C; Van Houtte P
    Radiother Oncol; 2009 Jan; 90(1):116-21. PubMed ID: 19013659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation dose and long term risk of cardiac pathology following radiotherapy and anthracyclin for a childhood cancer.
    Guldner L; Haddy N; Pein F; Diallo I; Shamsaldin A; Dahan M; Lebidois J; Merlet P; Villain E; Sidi D; Sakiroglu O; Hartmann O; Leftakopoulos D; de Vathaire F
    Radiother Oncol; 2006 Oct; 81(1):47-56. PubMed ID: 16989913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotoxicity from intensive chemotherapy combined with radiotherapy in breast cancer.
    de Graaf H; Dolsma WV; Willemse PH; van der Graaf WT; Sleijfer DT; de Vries EG; Mulder NH
    Br J Cancer; 1997; 76(7):943-5. PubMed ID: 9328157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and subclinical cardiac late effects in pediatric Hodgkin's lymphoma survivors.
    Materazzo C; Massimino M; Schiavello E; Podda M; Gandola L; Cefalo G; Catania S; Meazza C; Moschetti I; Terenziani M
    Tumori; 2017 Nov; 103(6):566-571. PubMed ID: 28708228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies.
    Schellong G; Riepenhausen M; Bruch C; Kotthoff S; Vogt J; Bölling T; Dieckmann K; Pötter R; Heinecke A; Brämswig J; Dörffel W
    Pediatr Blood Cancer; 2010 Dec; 55(6):1145-52. PubMed ID: 20734400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung function following treatment of malignant tumors with surgery, radiotherapy, or cyclophosphamide in childhood. A follow-up study after 11 to 27 years.
    Mäkipernaa A; Heino M; Laitinen LA; Siimes MA
    Cancer; 1989 Feb; 63(4):625-30. PubMed ID: 2914269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease.
    Bossi G; Cerveri I; Volpini E; Corsico A; Baio A; Corbella F; Klersy C; Arico M
    Ann Oncol; 1997; 8 Suppl 1():19-24. PubMed ID: 9187424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late cardiac effects after treatment for childhood Hodgkin's disease with chemotherapy and low-dose radiotherapy.
    Ilhan I; Sarialioglu F; Ozbarlas N; Büyükpamukçu M; Akyüz C; Kutluk T
    Postgrad Med J; 1995 Mar; 71(833):164-7. PubMed ID: 7746777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of cardiac function in patients with Hodgkin's disease treated with mediastinal irradiation and combination chemotherapy including doxorubicin.
    LaMonte CS; Yeh SD; Straus DJ
    Cancer Treat Rep; 1986 Apr; 70(4):439-44. PubMed ID: 2421892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma.
    Xu Y; Wang H; Zhou S; Yu M; Wang X; Fu K; Qian Z; Zhang H; Qiu L; Liu X; Wang P
    Leuk Lymphoma; 2013 Jul; 54(7):1396-404. PubMed ID: 23101661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support.
    Morgan RJ; Doroshow JH; Venkataraman K; Chang K; Raschko J; Somlo G; Leong L; Tetef M; Shibata S; Hamasaki V; Margolin K; Forman S; Akman S; Coluzzi P; Ahn C; Weiss L; Gadgil U; Harrison J
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2337-45. PubMed ID: 9815632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic findings in children treated for malignancy with chemotherapy including adriamycin.
    Solymar L; Marky I; Mellander L; Sabel KG
    Pediatr Hematol Oncol; 1988; 5(3):209-16. PubMed ID: 3152966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
    Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
    Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
    Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
    Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
    Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Side effects in chemoradiotherapy of bladder cancer].
    Shipilov VI; Gorbunova VA; Barkanov AI
    Vopr Onkol; 1989; 35(1):76-80. PubMed ID: 2919507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.